The prognostic landscape of genes and infiltrating immune cells across human cancers AJ Gentles, AM Newman, CL Liu, SV Bratman, W Feng, D Kim, VS Nair, ... Nature medicine 21 (8), 938-945, 2015 | 2840 | 2015 |
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage AM Newman, SV Bratman, J To, JF Wynne, NCW Eclov, LA Modlin, ... Nature medicine 20 (5), 548-554, 2014 | 2231 | 2014 |
Integrated digital error suppression for improved detection of circulating tumor DNA AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ... Nature biotechnology 34 (5), 547-555, 2016 | 1074 | 2016 |
Prediction of acute myeloid leukaemia risk in healthy individuals S Abelson, G Collord, SWK Ng, O Weissbrod, N Mendelson Cohen, ... Nature 559 (7714), 400-404, 2018 | 796 | 2018 |
Sensitive tumour detection and classification using plasma cell-free DNA methylomes SY Shen, R Singhania, G Fehringer, A Chakravarthy, MHA Roehrl, ... Nature 563 (7732), 579-583, 2018 | 719 | 2018 |
Circulating tumor DNA and liquid biopsy in oncology DW Cescon, SV Bratman, SM Chan, LL Siu Nature Cancer 1 (3), 276-290, 2020 | 397 | 2020 |
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ... Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015 | 345 | 2015 |
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab SV Bratman, SYC Yang, MAJ Iafolla, Z Liu, AR Hansen, PL Bedard, ... Nature Cancer 1 (9), 873-881, 2020 | 323 | 2020 |
FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution AM Newman, SV Bratman, H Stehr, LJ Lee, CL Liu, M Diehn, AA Alizadeh Bioinformatics 30 (23), 3390-3393, 2014 | 229 | 2014 |
Identification and Use of Circulating Nucleic Acid Tumor Markers M Diehn, AA Alizadeh, AM Newman, SV Bratman US Patent App. 14/774,518, 2016 | 212 | 2016 |
Nasopharyngeal cancer: molecular landscape JP Bruce, K Yip, SV Bratman, E Ito, FF Liu Journal of Clinical Oncology 33 (29), 3346-3355, 2015 | 164 | 2015 |
Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis X Zhao, P Psarianos, LS Ghoraie, K Yip, D Goldstein, R Gilbert, I Witterick, ... Nature metabolism 1 (1), 147-157, 2019 | 155 | 2019 |
Bioactive DNA from extracellular vesicles and particles EZ Malkin, SV Bratman Cell Death & Disease 11 (7), 584, 2020 | 154 | 2020 |
Stabilization of overlapping microtubules by fission yeast CLASP SV Bratman, F Chang Developmental cell 13 (6), 812-827, 2007 | 147 | 2007 |
Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA SY Shen, JM Burgener, SV Bratman, DD De Carvalho Nature protocols 14 (10), 2749-2780, 2019 | 146 | 2019 |
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates O Kis, R Kaedbey, S Chow, A Danesh, M Dowar, T Li, Z Li, J Liu, ... Nature communications 8 (1), 15086, 2017 | 142 | 2017 |
Senescence, necrosis, and apoptosis govern circulating cell-free DNA release kinetics A Rostami, M Lambie, WY Caberry, V Stambolic, JN Waldron, SV Bratman Cell reports 31 (13), 2020 | 141 | 2020 |
Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity‐modulated radiotherapy F Caparrotti, SH Huang, L Lu, SV Bratman, J Ringash, A Bayley, J Cho, ... Cancer 123 (19), 3691-3700, 2017 | 135 | 2017 |
Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy LJ McDowell, K Rock, W Xu, B Chan, J Waldron, L Lu, S Ezzat, D Pothier, ... International Journal of Radiation Oncology* Biology* Physics 102 (2), 340-352, 2018 | 132 | 2018 |
Identification and use of circulating tumor markers M Diehn, AA Alizadeh, AM Newman, SV Bratman US Patent App. 14/209,807, 2014 | 124 | 2014 |